collection
https://read.qxmd.com/read/26819807/endoscopic-and-laparoscopic-full-thickness-resection-of-endophytic-gastric-submucosal-tumors-very-close-to-the-esophagogastric-junction
#1
JOURNAL ARTICLE
Oh Kyoung Kwon, Wansik Yu
PURPOSE: Gastric submucosal tumors (SMTs) located very close to the esophagogastric junction (EGJ) are a challenge for gastric surgeons. Therefore, this study reports on the experience of using endoscopic and laparoscopic full-thickness resection (ELFR) with laparoscopic two-layer suturing in such tumors. MATERIALS AND METHODS: Six patients with gastric SMTs very close to the EGJ underwent ELFR with laparoscopic two-layer suturing at Kyungpook National University Medical Center...
December 2015: Journal of Gastric Cancer
https://read.qxmd.com/read/26069978/removal-of-a-large-40-mm-submucosal-leiomyoma-using-submucosal-tunneling-endoscopic-resection-and-extraction-of-specimen-using-a-distal-mucosal-incision
#2
JOURNAL ARTICLE
Jun Jie Ng, Philip W Y Chiu, Asim Shabbir, Jimmy B Y So
No abstract text is available yet for this article.
2015: Endoscopy
https://read.qxmd.com/read/25868871/thoracoscopic-and-laparoscopic-enucleation-of-esophageal-leiomyomas
#3
JOURNAL ARTICLE
Kfir Ben-David, Juan Alvarez, Georgios Rossidis, Kenny Desart, Thomas Caranasos, Steven Hochwald
Although infrequent, esophageal leiomyomas are the most common benign intramural tumors of the esophagus. As malignant potential is not a concern in these lesions, they represent ideal candidates for an organ-preserving approach. Due to their well-circumscribed growth, a minimally invasive approach should be pursued in almost all patients. We present our recent techniques and results associated with totally minimally invasive thoracoscopic and laparoscopic approaches to resection of esophageal leiomyomas. These approaches require technical expertise but can be accomplished with a short learning curve...
July 2015: Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/25697716/multivisceral-resections-for-gastrointestinal-stromal-tumors-are-the-risks-justifiable
#4
REVIEW
Jennifer M Racz, Supreet Sunil, Daniel Abramowitz, Savtaj S Brar, M Carolina Jimenez, Arash Azin, Eshetu G Atenafu, Timothy D Jackson, Allan Okrainec, Fayez A Quereshy
BACKGROUND: Surgical resection is the cornerstone of treatment for non-metastatic gastrointestinal stromal tumors (GISTs). Multivisceral resection (MVR) for locally advanced tumors is often required to achieve negative margins. The purpose of this study was to review the peri-operative and long-term oncologic outcomes for patients who required MVR versus single-organ resection (SOR) for GISTs. METHODS: All patients who underwent treatment for GISTs at a tertiary cancer center between 2001 and 2011 were identified...
March 2015: Surgical Oncology
https://read.qxmd.com/read/25671489/tailoring-gist-therapy%C3%A2-biology-is-still-king
#5
COMMENT
Ajay V Maker
No abstract text is available yet for this article.
April 2015: JAMA Surgery
https://read.qxmd.com/read/25605837/kit-and-pdgfra-mutations-and-the-risk-of-gi-stromal-tumor-recurrence
#6
JOURNAL ARTICLE
Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida, Sonja E Steigen, Peter Brabec, Lukas Plank, Bengt Nilsson, Chiara Braconi, Andrea Bordoni, Magnus K Magnusson, Jozef Sufliarsky, Massimo Federico, Jon G Jonasson, Isabelle Hostein, Pierre-Paul Bringuier, Jean-Francois Emile
PURPOSE: Mutated KIT and platelet-derived growth factor alpha gene (PDGFRA) drive GI stromal tumor (GIST) oncogenesis, but the clinical significance of their single mutations is known incompletely. PATIENTS AND METHODS: We identified 11 population-based series of patients with GIST through a literature search and pooled individual data from 3,067 patients treated with macroscopically complete tumor excision. Mutation analysis was done from 1,505 tumors. We analyzed associations between KIT and PDGFRA mutations and recurrence-free survival (RFS) in the subsets in which patients were treated with surgery alone...
February 20, 2015: Journal of Clinical Oncology
https://read.qxmd.com/read/23623056/gastrointestinal-stromal-tumour
#7
REVIEW
Heikki Joensuu, Peter Hohenberger, Christopher L Corless
Gastrointestinal stromal tumours (GISTs) are mesenchymal neoplasms that arise in the gastrointestinal tract, usually in the stomach or the small intestine and rarely elsewhere in the abdomen. They can occur at any age, the median age being 60-65 years, and typically cause bleeding, anaemia, and pain. GISTs have variable malignant potential, ranging from small lesions with a benign behaviour to fatal sarcomas. Most tumours stain positively for the mast/stem cell growth factor receptor KIT and anoctamin 1 and harbour a kinase-activating mutation in either KIT or PDGFRA...
September 14, 2013: Lancet
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.